دورية أكاديمية
Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders.
| العنوان: | Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders. |
|---|---|
| المؤلفون: | Mahaling B; Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Low SWY; Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Beck M; Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Kumar D; Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Ahmed S; Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Connor TB; Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA.; Vitreoretinal Surgery, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Ahmad B; Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA.; Vitreoretinal Surgery, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA., Chaurasia SS; Ocular Immunology and Angiogenesis Lab, Department of Ophthalmology and Visual Sciences, Froedtert and MCW Eye Institute, Medical College of Wisconsin, Milwaukee, WI 53226, USA.; Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI 53226, USA. |
| المصدر: | International journal of molecular sciences [Int J Mol Sci] 2022 Feb 26; Vol. 23 (5). Date of Electronic Publication: 2022 Feb 26. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI, [2000- |
| مواضيع طبية MeSH: | Alarmins* , Diabetic Retinopathy*, Humans ; Inflammation/pathology ; Receptor for Advanced Glycation End Products ; Toll-Like Receptors |
| مستخلص: | Damage-associated molecular patterns (DAMPs) are endogenous danger molecules released from the extracellular and intracellular space of damaged tissue or dead cells. Recent evidence indicates that DAMPs are associated with the sterile inflammation caused by aging, increased ocular pressure, high glucose, oxidative stress, ischemia, mechanical trauma, stress, or environmental conditions, in retinal diseases. DAMPs activate the innate immune system, suggesting their role to be protective, but may promote pathological inflammation and angiogenesis in response to the chronic insult or injury. DAMPs are recognized by specialized innate immune receptors, such as receptors for advanced glycation end products (RAGE), toll-like receptors (TLRs) and the NOD-like receptor family (NLRs), and purine receptor 7 (P2X7), in systemic diseases. However, studies describing the role of DAMPs in retinal disorders are meager. Here, we extensively reviewed the role of DAMPs in retinal disorders, including endophthalmitis, uveitis, glaucoma, ocular cancer, ischemic retinopathies, diabetic retinopathy, age-related macular degeneration, rhegmatogenous retinal detachment, proliferative vitreoretinopathy, and inherited retinal disorders. Finally, we discussed DAMPs as biomarkers, therapeutic targets, and therapeutic agents for retinal disorders. |
| References: | Clin Exp Ophthalmol. 2009 Apr;37(3):299-307. (PMID: 19472539) Ophthalmic Res. 1998;30(5):291-4. (PMID: 9704332) Front Neurosci. 2021 May 20;15:642176. (PMID: 34093110) Free Radic Biol Med. 2022 Mar;181:14-28. (PMID: 35091064) Clin Cancer Res. 2008 Feb 1;14(3):847-55. (PMID: 18245548) Arch Ophthalmol. 1986 Mar;104(3):417-21. (PMID: 3954643) Sci Rep. 2018 Mar 5;8(1):4032. (PMID: 29507358) Aging Cell. 2012 Aug;11(4):683-93. (PMID: 22577879) Neurobiol Dis. 2015 Feb;74:167-179. (PMID: 25478814) Invest Ophthalmol Vis Sci. 2008 May;49(5):1916-23. (PMID: 18223246) Mediators Inflamm. 2012;2012:196094. (PMID: 22973073) Cancer Med. 2020 Sep;9(17):6093-6101. (PMID: 32633890) Jpn J Ophthalmol. 2005 Mar-Apr;49(2):106-8. (PMID: 15838725) Exp Eye Res. 2008 Oct;87(4):367-75. (PMID: 18687328) Int J Ophthalmol. 2017 Jan 18;10(1):30-34. (PMID: 28149773) Invest Ophthalmol Vis Sci. 1995 Mar;36(3):571-8. (PMID: 7890488) Arch Ophthalmol. 1998 May;116(5):583-7. (PMID: 9596493) Nat Rev Cancer. 2015 Feb;15(2):96-109. (PMID: 25614008) Ocul Oncol Pathol. 2021 Mar;7(1):1-16. (PMID: 33796511) Biochem Biophys Res Commun. 2018 Sep 5;503(2):921-929. (PMID: 29932924) Cell Signal. 2020 Sep;73:109687. (PMID: 32497617) Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):4929-4936. (PMID: 30347087) Ageing Res Rev. 2015 Nov;24(Pt A):3-16. (PMID: 25446804) Invest Ophthalmol Vis Sci. 1990 Aug;31(8):1492-6. (PMID: 1696942) Acta Ophthalmol Scand. 1998 Dec;76(6):643-8. (PMID: 9881543) Cell Cycle. 2012 Jun 1;11(11):2084-91. (PMID: 22580469) Biology (Basel). 2021 Feb 24;10(3):. (PMID: 33668263) Int J Mol Sci. 2021 Feb 26;22(5):. (PMID: 33653000) PLoS One. 2018 Jul 12;13(7):e0199562. (PMID: 30001351) Clin Biochem. 2017 Dec;50(18):1110-1114. (PMID: 28964758) Arch Physiol Biochem. 2020 Jul 13;:1-8. (PMID: 32658632) Invest Ophthalmol Vis Sci. 2003 Mar;44(3):1299-304. (PMID: 12601062) Clin Cancer Res. 2012 Jul 15;18(14):3934-41. (PMID: 22645051) Cell Tissue Res. 2018 Feb;371(2):237-249. (PMID: 29064077) Invest Ophthalmol Vis Sci. 2005 Mar;46(3):1092-8. (PMID: 15728570) Diabetes Care. 2001 Feb;24(2):323-7. (PMID: 11213886) Int J Mol Sci. 2021 Jul 22;22(15):. (PMID: 34360582) Lab Invest. 2014 May;94(5):569-85. (PMID: 24614198) Int J Mol Sci. 2021 Jul 07;22(14):. (PMID: 34298915) J Neuroinflammation. 2015 Jul 30;12:137. (PMID: 26224068) Ophthalmologica. 1997;211(6):351-3. (PMID: 9380352) Int Ophthalmol. 2022 Feb;42(2):661-676. (PMID: 34796432) PLoS One. 2015 Sep 09;10(9):e0137358. (PMID: 26352837) Exp Eye Res. 2007 Nov;85(5):721-31. (PMID: 17870069) Exp Eye Res. 2013 May;110:1-9. (PMID: 23410824) Int J Mol Sci. 2017 Dec 14;18(12):. (PMID: 29240668) Invest Ophthalmol Vis Sci. 2009 Jun;50(6):2896-902. (PMID: 19151387) Invest Ophthalmol Vis Sci. 2000 Sep;41(10):3026-31. (PMID: 10967060) Atherosclerosis. 2009 Dec;207(2):374-83. (PMID: 19535079) Ger J Ophthalmol. 1993 Feb;2(1):28-31. (PMID: 7679595) Prog Retin Eye Res. 2018 Jan;62:24-37. (PMID: 28962928) Ophthalmologica. 2003 Nov-Dec;217(6):422-5. (PMID: 14573976) J Leukoc Biol. 2014 Apr;95(4):599-607. (PMID: 24374967) Curr Mol Med. 2021;21(3):237-245. (PMID: 32282301) Graefes Arch Clin Exp Ophthalmol. 2011 Nov;249(11):1649-60. (PMID: 21735240) J Ophthalmic Vis Res. 2015 Apr-Jun;10(2):151-4. (PMID: 26425317) Graefes Arch Clin Exp Ophthalmol. 2008 Jul;246(7):1053-8. (PMID: 18431589) Eur J Neurosci. 2003 Jul;18(1):61-75. (PMID: 12859338) Int J Cancer. 2006 Sep 1;119(5):1014-22. (PMID: 16570276) Curr Mol Med. 2013 Jan;13(1):24-57. (PMID: 22834835) Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1167-74. (PMID: 15906069) Graefes Arch Clin Exp Ophthalmol. 2016 Jan;254(1):97-108. (PMID: 26358273) Nephrol Dial Transplant. 2008 Mar;23(3):914-8. (PMID: 18003664) Curr Eye Res. 1982-1983;2(10):645-9. (PMID: 7186433) Cell Physiol Biochem. 2018;46(4):1650-1667. (PMID: 29694958) Sci Signal. 2019 Feb 12;12(568):. (PMID: 30755477) Sci Rep. 2018 Jun 14;8(1):9115. (PMID: 29904087) Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1783-91. (PMID: 10393049) Invest Ophthalmol Vis Sci. 2002 Apr;43(4):1135-41. (PMID: 11923257) Front Immunol. 2020 Mar 24;11:512. (PMID: 32265939) Front Immunol. 2019 Jul 16;10:1618. (PMID: 31379825) Nat Commun. 2017 Nov 17;8(1):1595. (PMID: 29150600) Int J Ophthalmol. 2019 May 18;12(5):795-801. (PMID: 31131239) Sci Rep. 2017 Mar 06;7:43470. (PMID: 28262779) Cell Death Discov. 2015 Nov 30;1:15058. (PMID: 27551484) Clin Exp Immunol. 1994 Aug;97(2):226-31. (PMID: 7519530) Clin Exp Ophthalmol. 2012 Nov;40(8):821-8. (PMID: 22429223) J Immunol. 2001 Sep 1;167(5):2887-94. (PMID: 11509636) Cell Signal. 2017 Dec;40:248-257. (PMID: 28970183) J Clin Med. 2019 May 31;8(6):. (PMID: 31159195) J Pathol. 2017 Jan;241(1):45-56. (PMID: 27701734) Eur J Immunol. 1998 Aug;28(8):2444-55. (PMID: 9710222) Eur J Immunol. 2014 Nov;44(11):3320-9. (PMID: 25116404) Biol Pharm Bull. 2015;38(4):601-10. (PMID: 25832640) Virulence. 2021 Dec;12(1):1362-1376. (PMID: 34009097) Mol Vis. 2016 Apr 30;22:436-45. (PMID: 27186070) J Neurosci. 2008 Dec 17;28(51):13765-74. (PMID: 19091967) Mol Cell Neurosci. 2014 May;60:88-96. (PMID: 24769106) Int J Pharm. 2021 Sep 5;606:120900. (PMID: 34293472) Invest Ophthalmol Vis Sci. 2001 Dec;42(13):3283-6. (PMID: 11726634) Br J Ophthalmol. 2006 Feb;90(2):213-7. (PMID: 16424536) JAMA Ophthalmol. 2017 Nov 1;135(11):1221-1230. (PMID: 29049475) Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):34. (PMID: 32716502) J Neurochem. 1994 Aug;63(2):737-50. (PMID: 8035198) Int J Ophthalmol. 2018 Oct 18;11(10):1600-1607. (PMID: 30364183) Front Immunol. 2017 Feb 14;8:142. (PMID: 28261206) World J Gastroenterol. 2018 Nov 7;24(41):4622-4634. (PMID: 30416310) Diabetes. 2006 Jan;55(1):86-92. (PMID: 16380480) J Neuroinflammation. 2014 Feb 18;11:33. (PMID: 24548736) J AAPOS. 1998 Dec;2(6):369-71. (PMID: 10532727) Ophthalmic Res. 2012;48(2):67-74. (PMID: 22472973) Transl Oncol. 2021 Feb;14(2):100995. (PMID: 33338880) Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7653-60. (PMID: 26624497) Cell Mol Life Sci. 2021 May;78(9):4069-4083. (PMID: 33544155) Neuroscience. 2008 Aug 26;155(3):937-47. (PMID: 18640247) PLoS One. 2011 Apr 27;6(4):e19141. (PMID: 21556354) Eye (Lond). 2003 Nov;17(8):949-56. (PMID: 14631402) Arch Ophthalmol. 1988 Mar;106(3):392-5. (PMID: 3278704) PLoS One. 2018 Oct 8;13(10):e0205292. (PMID: 30296277) Am J Pathol. 2011 Dec;179(6):2798-809. (PMID: 21983632) Prog Retin Eye Res. 2019 Nov;73:100763. (PMID: 31150824) Am J Cancer Res. 2013;3(1):1-20. (PMID: 23359863) EMBO Mol Med. 2022 Jan 11;14(1):e14511. (PMID: 34779136) Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2130-8. (PMID: 11481282) Mediators Inflamm. 2014;2014:728673. (PMID: 25580061) Int J Mol Sci. 2021 Feb 20;22(4):. (PMID: 33672611) J Immunol. 2011 Jun 1;186(11):6119-28. (PMID: 21508263) Braz J Med Biol Res. 2010 Jul;43(7):627-33. (PMID: 20464343) Arch Ophthalmol. 1999 Jul;117(7):917-24. (PMID: 10408457) Diabetologia. 2020 Oct;63(10):2235-2248. (PMID: 32734440) Front Neuroanat. 2016 Apr 29;10:46. (PMID: 27199678) J Leukoc Biol. 2003 Aug;74(2):179-85. (PMID: 12885934) Immune Netw. 2018 Aug 13;18(4):e27. (PMID: 30181915) PLoS One. 2012;7(1):e29830. (PMID: 22253793) Am J Med. 2003 Jun 1;114(8):638-46. (PMID: 12798451) Invest Ophthalmol Vis Sci. 2011 Jul 07;52(8):5049-57. (PMID: 21596823) J Cell Mol Med. 2016 Nov;20(11):2122-2137. (PMID: 27374750) Invest Ophthalmol Vis Sci. 2008 Feb;49(2):511-21. (PMID: 18234993) PLoS One. 2013 Jul 05;8(7):e68149. (PMID: 23861862) Exp Eye Res. 2014 Oct;127:49-58. (PMID: 25041941) Cell Death Dis. 2014 Mar 06;5:e1105. (PMID: 24603333) Mol Vis. 2021 Jul 08;27:438-456. (PMID: 34295142) Ophthalmologica. 1993;206(3):133-8. (PMID: 8272335) Cancers (Basel). 2020 Oct 11;12(10):. (PMID: 33050649) Invest Ophthalmol Vis Sci. 2001 Nov;42(12):3047-57. (PMID: 11687554) Eur J Ophthalmol. 2016 Nov 4;26(6):633-638. (PMID: 27198637) J Surg Res. 2014 Oct;191(2):350-61. (PMID: 24862878) J Ophthalmol. 2018 Oct 24;2018:5195290. (PMID: 30473885) Aging (Albany NY). 2019 Jul 7;11(13):4323-4337. (PMID: 31284269) Ageing Res Rev. 2009 Apr;8(2):128-39. (PMID: 19274853) Invest Ophthalmol Vis Sci. 2015 Jun;56(6):3743-57. (PMID: 26066743) Int J Biochem Cell Biol. 2015 Jul;64:1-10. (PMID: 25783987) FASEB J. 2001 Mar;15(3):559-61. (PMID: 11259366) FEBS Lett. 2018 Dec;592(23):3806-3818. (PMID: 29729013) Mol Vis. 2012;18:1197-214. (PMID: 22665967) Curr Eye Res. 2008 Mar;33(3):253-61. (PMID: 18350436) Aging Cell. 2018 Aug;17(4):e12710. (PMID: 29730901) Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13444-9. (PMID: 17684098) PLoS One. 2013;8(1):e53338. (PMID: 23308196) Cold Spring Harb Perspect Med. 2014 Jul 03;4(8):. (PMID: 24993677) Mol Vis. 2013 May 29;19:1125-31. (PMID: 23734081) J Immunol. 2007 Jun 15;178(12):8158-67. (PMID: 17548654) Medicine (Baltimore). 2015 Oct;94(42):e1858. (PMID: 26496336) J Mol Med (Berl). 2019 Mar;97(3):341-354. (PMID: 30617853) Front Immunol. 2019 Sep 13;10:2025. (PMID: 31572353) J Cell Biochem. 2004 Nov 1;93(4):708-20. (PMID: 15660415) Ann N Y Acad Sci. 2005 Aug;1053:74-83. (PMID: 16179510) Exp Eye Res. 2006 May;82(5):807-15. (PMID: 16364297) Brain Res. 2003 Apr 25;970(1-2):119-30. (PMID: 12706253) Ocul Surf. 2014 Jan;12(1):23-31. (PMID: 24439044) Ophthalmic Res. 2011;46(2):73-9. (PMID: 21242702) Biull Eksp Biol Med. 1982 Nov;94(11):21-3. (PMID: 7150729) Eye (Lond). 2016 Jun;30(6):877-87. (PMID: 26987588) Mol Vis. 2011 Feb 17;17:508-18. (PMID: 21365018) Can J Ophthalmol. 2008 Jun;43(3):356-60. (PMID: 18493277) Exp Biol Med (Maywood). 2017 Jan;242(1):1-7. (PMID: 27798121) Int J Mol Sci. 2020 May 25;21(10):. (PMID: 32466215) J Diabetes Complications. 2017 Jan;31(1):245-252. (PMID: 27452162) Mediators Inflamm. 2012;2012:493043. (PMID: 23055574) Int J Mol Sci. 2020 Jan 30;21(3):. (PMID: 32019187) Curr Eye Res. 2008 Jan;33(1):101-7. (PMID: 18214747) Tumour Biol. 2007;28(2):63-9. (PMID: 17264538) Exp Eye Res. 2020 Dec;201:108281. (PMID: 33031790) Matrix Biol. 2016 May-Jul;52-54:141-150. (PMID: 27072616) Invest Ophthalmol Vis Sci. 2011 Sep 09;52(10):7187-94. (PMID: 21828158) Am J Pathol. 2011 Mar;178(3):1080-91. (PMID: 21356360) Cardiovasc Diabetol. 2014 Feb 07;13:38. (PMID: 24502618) Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5697-707. (PMID: 20538986) Cell Death Dis. 2020 Sep 26;11(9):811. (PMID: 32980857) CNS Neurosci Ther. 2016 Apr;22(4):291-7. (PMID: 26842741) Br J Ophthalmol. 2004 May;88(5):667-72. (PMID: 15090421) Infect Immun. 2008 Apr;76(4):1781-90. (PMID: 18227158) PLoS One. 2010 Oct 01;5(10):. (PMID: 20957206) Med J Malaysia. 2010 Mar;65(1):36-40. (PMID: 21265246) Autophagy. 2014 Mar;10(3):442-52. (PMID: 24418846) Diabetes Res Clin Pract. 2008 Dec;82(3):317-23. (PMID: 18922595) Adv Exp Med Biol. 2018;1074:19-28. (PMID: 29721923) J Histochem Cytochem. 2012 Dec;60(12):963-75. (PMID: 22821552) Ukr Biokhim Zh (1999). 2008 Sep-Oct;80(5):5-44. (PMID: 19248616) Lab Invest. 2016 Nov;96(11):1178-1188. (PMID: 27668890) Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):330-8. (PMID: 23241411) J Mol Neurosci. 2015 Jun;56(2):431-9. (PMID: 25676032) Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2758-66. (PMID: 12147613) Mol Med Rep. 2015 Nov;12(5):6577-83. (PMID: 26352383) Int J Gen Med. 2021 Aug 18;14:4639-4651. (PMID: 34434056) Mol Immunol. 2017 Oct;90:42-49. (PMID: 28697404) Oncotarget. 2017 Jan 10;8(2):2816-2824. (PMID: 27926530) Diabetes Care. 2002 Oct;25(10):1899. (PMID: 12351514) PLoS One. 2010 Oct 20;5(10):e13493. (PMID: 20975989) J Histochem Cytochem. 2018 Apr;66(4):213-227. (PMID: 29290139) Angiogenesis. 2018 Feb;21(1):95-109. (PMID: 29318471) Scand J Immunol. 2013 Jun;77(6):476-81. (PMID: 23701436) EMBO Mol Med. 2018 Oct;10(10):. (PMID: 30224384) Eye (Lond). 2013 Feb;27(2):128-36. (PMID: 23154492) Cold Spring Harb Perspect Med. 2014 May 05;4(7):a017194. (PMID: 24799364) Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1581-1589. (PMID: 31336525) Sci Rep. 2021 May 7;11(1):9766. (PMID: 33963197) PLoS One. 2017 May 30;12(5):e0178230. (PMID: 28558009) Chem Biol Interact. 2016 May 25;252:141-9. (PMID: 27062892) Cell Mol Life Sci. 2016 Nov;73(22):4279-4297. (PMID: 27333888) PLoS One. 2017 May 23;12(5):e0178236. (PMID: 28542588) Curr Eye Res. 2011 Nov;36(11):1037-46. (PMID: 21999229) Int J Proteomics. 2010;2010:479571. (PMID: 22084677) Eur J Pharmacol. 2015 Jun 5;756:52-8. (PMID: 25796199) PLoS One. 2012;7(10):e47098. (PMID: 23056591) Mol Vis. 2005 Apr 28;11:298-308. (PMID: 15889014) Invest Ophthalmol Vis Sci. 2011 Jun 01;52(6):3521-9. (PMID: 21273542) Prog Retin Eye Res. 2012 Mar;31(2):182-94. (PMID: 22120610) FASEB J. 2007 Jul;21(9):2113-23. (PMID: 17400913) Jpn J Ophthalmol. 1992;36(1):76-83. (PMID: 1635299) Cell Death Differ. 2014 Feb;21(2):270-7. (PMID: 23954861) Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3059-65. (PMID: 12824252) Mol Diagn Ther. 2020 Jun;24(3):251-262. (PMID: 32248387) Vaccines (Basel). 2018 Sep 14;6(3):. (PMID: 30223448) Matrix Biol Plus. 2020 Apr 03;8:100034. (PMID: 33543033) Front Immunol. 2018 Jan 05;8:1908. (PMID: 29379499) Nature. 2011 Mar 17;471(7338):325-30. (PMID: 21297615) Brain Res Bull. 2019 Sep;151:153-163. (PMID: 30593878) Cureus. 2020 Jul 2;12(7):e8960. (PMID: 32766003) Invest Ophthalmol Vis Sci. 2014 Aug 05;55(9):5466-75. (PMID: 25097240) J Clin Med. 2014;3(4):1542-60. (PMID: 25580276) BMC Ophthalmol. 2018 Apr 16;18(1):96. (PMID: 29661181) BMC Med Genomics. 2008 Jun 13;1:26. (PMID: 18554398) Neuropathology. 2010 Aug;30(4):401-7. (PMID: 20102525) Int J Clin Exp Pathol. 2013 Jun 15;6(7):1230-44. (PMID: 23826405) FEBS J. 2019 Aug;286(15):2883-2908. (PMID: 30724463) Ocul Immunol Inflamm. 2021 Sep 3;:1-7. (PMID: 34477485) J Mol Neurosci. 2015 May;56(1):228-36. (PMID: 25577368) JOJ Ophthalmol. 2017;4(4):. (PMID: 29376145) Mol Vis. 2013;19:665-74. (PMID: 23559860) Lasers Med Sci. 2020 Oct;35(8):1663-1670. (PMID: 32435907) Ocul Immunol Inflamm. 2021;29(7-8):1616-1620. (PMID: 35169380) Curr Eye Res. 2017 Sep;42(9):1319-1326. (PMID: 28632409) Eur J Neurosci. 2020 Jun;51(12):2394-2411. (PMID: 31883161) Pathol Oncol Res. 2015 Sep;21(4):1237-42. (PMID: 26118980) Sci Rep. 2020 Jun 9;10(1):9299. (PMID: 32518264) Sci Rep. 2017 Aug 29;7(1):9672. (PMID: 28852052) Case Rep Ophthalmol. 2018 May 24;9(2):279-282. (PMID: 29928223) J Leukoc Biol. 2007 Jan;81(1):1-5. (PMID: 17032697) Sci Rep. 2017 May 18;7(1):2062. (PMID: 28522876) Adv Exp Med Biol. 2016;854:161-7. (PMID: 26427407) Invest Ophthalmol Vis Sci. 1995 Jan;36(1):24-31. (PMID: 7822152) Graefes Arch Clin Exp Ophthalmol. 2015 May;253(5):699-704. (PMID: 25056526) Nat Med. 2009 Jul;15(7):774-80. (PMID: 19561617) Curr Mol Med. 2007 Dec;7(8):758-65. (PMID: 18331234) Nanoscale. 2018 Sep 13;10(35):16485-16498. (PMID: 29897081) Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4661-4669. (PMID: 31725165) PLoS One. 2015 Jun 08;10(6):e0128423. (PMID: 26053426) Life (Basel). 2021 Dec 17;11(12):. (PMID: 34947953) Lab Invest. 2009 Mar;89(3):278-89. (PMID: 19139725) Invest Ophthalmol Vis Sci. 2005 Jan;46(1):191-6. (PMID: 15623773) Ageing Res Rev. 2015 Nov;24(Pt A):29-39. (PMID: 25641058) Exp Eye Res. 2019 Feb;179:125-131. (PMID: 30445048) Vascular. 2018 Aug;26(4):378-386. (PMID: 29360007) PLoS One. 2013 Dec 20;8(12):e80288. (PMID: 24376495) Clin Ophthalmol. 2010 Feb 18;4:73-6. (PMID: 20186280) Int Rev Immunol. 2013 Feb;32(1):42-56. (PMID: 23360157) Front Immunol. 2016 Oct 24;7:444. (PMID: 27822213) Mol Vis. 2017 Dec 05;23:853-871. (PMID: 29259392) Eye (Lond). 2020 Sep;34(9):1672-1678. (PMID: 31844164) Ophthalmic Res. 2015;53(1):2-7. (PMID: 25472810) Cells. 2019 Nov 26;8(12):. (PMID: 31779192) Br J Ophthalmol. 2010 Mar;94(3):271-4. (PMID: 19264730) Front Immunol. 2018 Apr 05;9:708. (PMID: 29675026) Apoptosis. 2014 Apr;19(4):603-14. (PMID: 24337820) Invest Ophthalmol Vis Sci. 2015 May;56(5):2971-9. (PMID: 25829413) Cell Death Dis. 2015 Apr 23;6:e1731. (PMID: 25906154) Int J Mol Sci. 2019 Oct 18;20(20):. (PMID: 31635205) Cancer Res. 2000 Jul 15;60(14):3940-6. (PMID: 10919672) Sci Rep. 2018 Feb 12;8(1):2847. (PMID: 29434227) J Neuroinflammation. 2019 Dec 3;16(1):251. (PMID: 31796062) Graefes Arch Clin Exp Ophthalmol. 2010 Feb;248(2):243-8. (PMID: 19763599) |
| معلومات مُعتمدة: | R01 EY029795 United States EY NEI NIH HHS; RO1EY029795 National Institute of Health |
| فهرسة مساهمة: | Keywords: DAMPs; age-related macular degeneration; diabetic retinopathy; endophthalmitis; glaucoma; inherited retinal disorders; ischemic retinopathies; ocular cancer; proliferative vitreoretinopathy; uveitis |
| المشرفين على المادة: | 0 (Alarmins) 0 (Receptor for Advanced Glycation End Products) 0 (Toll-Like Receptors) |
| تواريخ الأحداث: | Date Created: 20220310 Date Completed: 20220408 Latest Revision: 20220510 |
| رمز التحديث: | 20221213 |
| مُعرف محوري في PubMed: | PMC8910759 |
| DOI: | 10.3390/ijms23052591 |
| PMID: | 35269741 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms23052591 |